Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

GSK

GSK (GSK)

GSK plc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NYSE:GSK
日付受信時刻ニュースソース見出しコード企業名
2024/05/2120 : 18IH Market NewsCalPERS to Oppose Exxon Mobil Directors; Microsoft Unveils Copilot+ PCs with AI Focus, and More NewsNYSE:GSKGSK plc
2024/05/2119 : 17Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:GSKGSK plc
2024/05/2023 : 49Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:GSKGSK plc
2024/05/1720 : 36IH Market NewsOpenAI’s Reddit Partnership Boosts Shares by 14%, Microsoft Embraces AMD Chips for AI, and More NewsNYSE:GSKGSK plc
2024/05/1719 : 00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:GSKGSK plc
2024/05/1323 : 49Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:GSKGSK plc
2024/05/0714 : 00GlobeNewswire Inc.BioVersys Announces Expansion of Strategic Collaboration With GSK and Extension of Its Series C Round by CHF 12.3 MillionNYSE:GSKGSK plc
2024/04/2620 : 48IH Market NewsAnglo American Rejects BHP Group’s Offer, Toyota Invests $1.4 Billion in Indiana, and More NewsNYSE:GSKGSK plc
2024/03/1621 : 00Business WirePositive RUBY phase III data show potential for Jemperli (dostarlimab-gxly) combinations in more patients with primary advanced or recurrent endometrial cancerNYSE:GSKGSK plc
2024/03/0902 : 48Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:GSKGSK plc
2024/03/0802 : 00Business WireGSK Doubles COiMMUNITY Grant Funding, Launches Patient Resources, as Adult Vaccination Rates Begin to Show Promising RiseNYSE:GSKGSK plc
2024/03/0720 : 13Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:GSKGSK plc
2024/03/0701 : 11Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:GSKGSK plc
2024/03/0603 : 09Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:GSKGSK plc
2024/03/0602 : 30Edgar (US Regulatory)Form IRANNOTICE - Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act Section 13(r)).NYSE:GSKGSK plc
2024/03/0602 : 10Edgar (US Regulatory)Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]NYSE:GSKGSK plc
2024/03/0520 : 10Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:GSKGSK plc
2024/03/0200 : 29Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:GSKGSK plc
2024/03/0123 : 55Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:GSKGSK plc
2024/02/2920 : 27Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:GSKGSK plc
2024/02/2920 : 27Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:GSKGSK plc
2024/02/2920 : 11IH Market NewsShares of WW International Plummet after Oprah Exits, EA Announces Workforce Reduction and Restructuring Plan, and Latest NewsNYSE:GSKGSK plc
2024/02/2700 : 38Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:GSKGSK plc
2024/02/2620 : 39Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:GSKGSK plc
2024/02/2300 : 45Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:GSKGSK plc
2024/02/1520 : 34IH Market NewsCisco Systems Stock Drops 5% Following Restructuring Plan, Berkshire Trims Apple Stake, and Latest NewsNYSE:GSKGSK plc
2024/02/0821 : 00GlobeNewswire Inc.Alector Announces First Patient Dosed in PROGRESS-AD Phase 2 Clinical Trial of AL101/GSK4527226 in Patients with Early Alzheimer’s DiseaseNYSE:GSKGSK plc
2024/02/0806 : 01GlobeNewswire Inc.23andMe Reports Third Quarter Fiscal 2024 Financial ResultsNYSE:GSKGSK plc
2024/02/0721 : 00GlobeNewswire Inc.FDA Grants Latozinemab Breakthrough Therapy Designation for Frontotemporal Dementia Due to a Progranulin Gene Mutation (FTD-GRN)NYSE:GSKGSK plc
2024/02/0621 : 00Business WireGSK’s RSV Vaccine, AREXVY, Accepted Under Priority Review in US for the Prevention of RSV Disease in Adults Aged 50-59 at Increased RiskNYSE:GSKGSK plc
 Showing the most relevant articles for your search:NYSE:GSK

最近閲覧した銘柄

Delayed Upgrade Clock